Breaking news, press release distribution, targeting and monitoring, public relations and investor relations services, multimedia and press release optimization, enhanced online news, and regulatory filings

Latest Press Releases	Get News Alerts by RSS

	> View All Press Releases

Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibitex, Inc.

02/03/2012 - 07:30 AM

BUSINESS WIRE

Bristol-Myers Squibb Delivers Solid Fourth Quarter Capping a Year Highlighted by New Product Approvals, Continued Execution of Strategic Transactions and Good Operating Performance

01/26/2012 - 07:30 AM

BUSINESS WIRE

Bristol-Myers Squibb Names Gerald L. Storch to Board of Directors

01/24/2012 - 10:07 AM

BUSINESS WIRE

Bristol-Myers Squibb Announces Charitable Donation of $6.9 Million to Support Cancer Patients

01/19/2012 - 08:30 AM

BUSINESS WIRE

Bristol-Myers Squibb and AstraZeneca Receive Complete Response Letter from U.S. Food and Drug Administration for Dapagliflozin

01/19/2012 - 02:00 AM

BUSINESS WIRE

First Hepatitis C Treatment Data Demonstrating Proof of Principle with Direct-Acting Antiviral-only Therapy Published

01/18/2012 - 05:01 PM

BUSINESS WIRE

Bristol-Myers Squibb Begins Tender Offer to Acquire Inhibitex, Inc.

01/13/2012 - 07:30 AM

BUSINESS WIRE

Bristol-Myers Squibb to Acquire Inhibitex

01/07/2012 - 09:13 PM

BUSINESS WIRE

Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2011 on January 26

01/05/2012 - 02:00 PM

BUSINESS WIRE

Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference

01/04/2012 - 10:30 AM

BUSINESS WIRE

Bristol-Myers Squibb to Present at Goldman Sachs Healthcare CEOs Unscripted Conference

12/29/2011 - 02:13 PM

BUSINESS WIRE

BRISK-PS Study with Investigational Compound Brivanib in Hepatocellular Carcinoma Completed

12/22/2011 - 04:30 PM

BUSINESS WIRE

Bristol-Myers Squibb and the Gladstone Institutes Enter Three-Year Discovery Partnership in Alzheimer’s Disease

12/22/2011 - 01:00 PM

BUSINESS WIRE

Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound

12/13/2011 - 07:00 PM

BUSINESS WIRE

New Data Show Investigational Compound Dapagliflozin When Added to Glimepiride Maintained Reductions in Blood Sugar Levels in Adults with Type 2 Diabetes Over 48 Weeks of Treatment

12/08/2011 - 03:30 AM

BUSINESS WIRE

Bristol-Myers Squibb Announces Dividend Increase

12/06/2011 - 05:05 PM

BUSINESS WIRE

Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals for Phase II Combination Study in Patients Chronically Infected with Hepatitis C

12/02/2011 - 07:30 AM

BUSINESS WIRE

Alvin Ailey American Dance Theater Premieres Home, A New Work Inspired by the Winning Photos and Essays from the 2011 REYATAZ® (atazanavir sulfate) “Fight HIV Your Way” Contest, an Initiative of Bristol-Myers Squibb

11/30/2011 - 10:00 AM

BUSINESS WIRE

FDA Accepts ELIQUIS® (apixaban) New Drug Application for Review for the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation

11/29/2011 - 07:30 AM

BUSINESS WIRE

ONGLYZA® (saxagliptin) Approved for Use in Europe as Combination Therapy With Insulin (With or Without Metformin) in Adults With Type 2 Diabetes

11/28/2011 - 08:00 AM

BUSINESS WIRE

Bristol-Myers Squibb Foundation Awards $2.34 Million in Grants to Help Prisoners with Mental Illness Return to Community

11/17/2011 - 10:00 AM

BUSINESS WIRE

Meta-Analysis of Clinical Data on Cardiovascular Safety Presented for Investigational Compound Dapagliflozin in Adult Patients with Type 2 Diabetes

11/16/2011 - 04:00 PM

BUSINESS WIRE

Bristol-Myers Squibb Foundation’s Together on Diabetes® Initiative Marks First Anniversary by Awarding $18.4 Million in Grants to Help Communities Hardest Hit by Diabetes, Issuing Annual Report

11/14/2011 - 11:58 AM

BUSINESS WIRE

New Data Presented On Phase 3 Trial Of ELIQUIS® (apixaban) In The Prevention Of Venous Thromboembolism In Patients With Acute Medical Illness

11/13/2011 - 08:01 AM

BUSINESS WIRE

Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz® (atazanavir sulfate) in Brazil

11/11/2011 - 09:05 AM

BUSINESS WIRE